Reykjavik, Iceland

Bjarki Stefansson

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Enzymatica Ab. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bjarki Stefansson. Retrieved from https://idiyas.com/inventor/bjarki-stefansson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bjarki Stefansson: Innovator in Trypsin Isoforms

Introduction

Bjarki Stefansson is a notable inventor based in Reykjavik, Iceland. He has made significant contributions to the field of biochemistry, particularly in the development of novel trypsin isoforms. With a total of 2 patents, his work has implications in various industries, including medical devices, pharmaceuticals, and cosmetics.

Latest Patents

Stefansson's latest patents focus on the innovative use of trypsin ZT isoforms. The first patent details the novel trypsin ZT isoforms and their applications in medical devices, pharmaceuticals, and cosmetics. This invention highlights the potential of these isoforms to enhance product efficacy and safety. The second patent reiterates the same focus on trypsin ZT isoforms, emphasizing their versatility and importance in various applications.

Career Highlights

Bjarki Stefansson is currently associated with Enzymatica AB, a company that specializes in enzyme-based solutions. His work at Enzymatica has allowed him to explore the practical applications of his inventions in real-world scenarios. His contributions have positioned him as a key player in the field of enzymatic research and development.

Collaborations

Stefansson has collaborated with several professionals in his field, including Agusta Gudmundsdottir and Asgeir Asgeirsson. These collaborations have fostered a productive environment for innovation and have led to advancements in their shared research interests.

Conclusion

Bjarki Stefansson's work in the development of trypsin isoforms showcases his commitment to innovation in biochemistry. His patents reflect a deep understanding of the potential applications of his inventions, making significant strides in the medical and cosmetic industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…